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ABSTRACT
Serious infections due to antibiotic-resistant bacteria are pervasive, and of particular concern within hospital
units due to frequent interaction among health-care workers and patients. Such nosocomial infections are
difficult to eliminate because of inconsistent disinfection procedures and frequent interactions among
infected persons, and because ill-chosen antibiotic treatment strategies can lead to a growth of resistant
bacterial strains. Clinical studies to address these concerns have several issues, but chief among them are
the effects on the patients involved. Realistic simulation models offer an attractive alternative. This paper
presents a hybrid simulation model of antibiotic resistant infections in a hospital ward, combining agent-
based simulation to model the inter-host interactions of patients and health-care workers with a detailed
differential equations and probabilistic model of intra-host bacterial and antibiotic dynamics. Initial results
to benchmark the model demonstrate realistic behavior and suggest promising extensions to achieve a
highly-complex yet accurate mechanism for testing antibiotic strategies.
1 INTRODUCTION
The status of health-care associated infections (HAI), also known as nosocomial infections, as a serious
health threat is well-documented. The Centers for Disease Control and Prevention (CDC) reports that
approximately 1.7 million HAIs occur in American hospitals each year, resulting in approximately 99,000
deaths and $20 billion in associated healthcare costs (Klevens et al. 2007). The threat of HAIs is greatly
compounded by the rise of antibiotic resistance among many of the more dangerous human pathogens. Such
resistance often results in increased treatment failures, which in turn lead to infections that are both more
deadly and more costly than their antibiotic-sensitive counterparts (Stein 2005). Moreover, the problem
is widespread — the CDC reports that more than 70% of the bacteria that cause HAIs are resistant to at
least one of the antibiotics most commonly used to treat them, and, according to one study, nearly 20% of
pathogens from HAIs are multi-drug resistant phenotypes (Sievert et al. 2013).
In response to this public health threat, a number of individuals and groups have proposed strategies to
control the rise and spread of antibiotic resistance in hospital pathogens (Goldmann et al. 1996, Spellberg
et al. 2008). Some of these strategies focus on active management of antibiotic usage because of the ability
of the drugs to impact the natural selection process at the bacterial level. Many of the suggested strategies
involve careful stewardship over the use of antibiotics (Farr et al. 2001), including cycling, substitution,
and combination therapy.
Careful testing of the relative effectiveness of these antibiotic management strategies is needed, but
only a very small number of these proposed strategies have been hospital-tested with regard to their impact
on antibiotic-resistant infections, primarily because of (1) the large number of factors that can influence the
infection dynamics, and (2) the health risks and ethical issues inherent in any controlled study involving
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treatment of humans. A mathematical and computational model simulating infection dynamics in a hospital
unit offers the potential to run controlled experiments specifically designed to test the relative merits of
each management strategy in an inexpensive way that does not place patients at risk, and may even identify
novel strategies for minimizing the threat of antibiotic-resistant infections.
When considering any mathematical or computer simulation model of antibiotic-resistant dynamics,
there are two distinct levels that are important to capture. Intra-host dynamics refers to bacterial-level
processes that take place inside each individual human host and includes bacterial population dynamics
(reproduction and natural death), changes in resistance due to genetic mutations, plasmid-mediated resistance,
pharmacokinetic and pharmacodynamic properties of antibiotics, antibiotic-bacteria interactions, bacterial
interactions with the host immune system, interactions between bacterial strains with different resistance
profiles, and interaction between bacterial species. Inter-host dynamics refers to interactions at the human-
level, principally the transfer of bacteria between individuals, and includes different types of interactions
among patients and health-care workers (HCWs), and antibiotic treatment decisions and applications.
This work aims to provide a highly realistic model for simulating HCW, patient, bacterial, and antibiotic
dynamics as they relate to the rise and spread of antibiotic-resistant HAIs, offering the ability to carefully
test existing antibiotic management strategies and, possibly, to generate new strategies. Our model:
• combines intra-host dynamics and inter-host dynamics into a single, unified, realistic model that is
sufficiently flexible to permit simulation of many of the management strategies listed above;
• naturally includes a heterogeneous population of individuals in the hospital ward, unlike traditional
SIR-type approaches;
• allows the inclusion of many bacterial species — with parameter values that reflect differences
among them — and a range of strains within each species, each with distinct resistance profiles
and multiple levels of resistance;
• permits genetic changes within bacteria to alter antibiotic resistance profiles;
• permits a wide range of antibiotic choices, with pharmacokinetic (and other) parameter values that
reflect the behavior of each; and
• allows for multiple categories of host colonization or infection (i.e., more than simply “colonized”
or “uncolonized”), with different likelihood of spread between hosts.
This paper describes the combination of the intra- and inter-host models, and provides preliminary results
demonstrating the ability of the hybrid model to capture the complex dynamics associated with antibiotic
resistant HAIs within a single hospital ward.
The remainder of this paper is organized as follows. Section 2 discusses related work. The inter-host
and intra-host models are discussed in Section 3. Section 4 presents preliminary experiments and results
using our model, and Section 5 provides conclusions and future directions.
2 RELATED WORK
Models addressing antibiotic resistance now generally fall into one of two categories: compartmental
(population dynamics) models or agent-based simulation models. By far the most common approach is
to model infection dynamics using the so-called SIR models, in which patient (and HCW, if included)
populations are divided into categories (compartments), with underlying systems of differential equations
describing rates of transition from one category to another, e.g., recent works that focus on control strategies
within hospital units (D’Agata et al. 2005), facilities other than hospitals (Chamchod and Ruan 2012b), or
to suggest coordination at a regional level (Smith et al. 2004). One primary drawback of compartmental
models is the frequent assumption that each compartment consists of a set of homogeneous individuals.
Incorporating complex transmission dynamics between patients and HCWs is limited with this approach,
although some heterogeneity can be introduced (Bootsma et al. 2006). In addition, many of the published
works thus far have focused primarily on preventative control strategies (e.g., hand hygiene, patient screening,
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decolonization), although a few recent studies have focused on treatment and antibiotic history (Chamchod
and Ruan 2012a) or on quantifying the contribution of antibiotic exposure (D’Agata et al. 2005).
Because of the ability to easily model heterogeneous populations, agent-based simulation models
apply well in this context. Similar to the SIR-model work, most agent-based models focus on simulating
control strategies (Barnes et al. 2010, Meng et al. 2010). One recent agent-based approach focuses on
community-associated antibiotic resistance (Macal et al. 2012), an even more challenging problem that
requires modeling dynamics throughout the entire community. Perhaps the closest related work is the
combination of agent-based simulation with loosely-coupled system dynamics (Djanatliev et al. 2012),
although the application to mobile stroke units is different than our focus, and modeling population and
disease dynamics using system dynamics differs from our in-host model.
The contribution of our work lies primarily in the tight integration of agent-based simulation, which
naturally models heterogeneous populations and allows for modeling complex interactions at the human
level, with a very detailed differential equations model of in-host bacterial and antibiotic dynamics. Recent
work comparing differential equations models with agent-based simulation concludes that the former are
more tractable while the latter allow for heterogeneity and complexity (Rahmandad and Sterman 2008).
Moreover, a recent call for multi-agent simulation (MAS) (Helbing and Balietti 2011) points out that these
models provide natural heterogeneity, can be easily combined (bridged) with other types of models, and
are well suited for detailed hypothesis testing. Our work is therefore timely and appropriate, allowing for
careful combination of two generally disparate approaches.
3 HYBRID AGENT-BASED AND DIFFERENTIAL EQUATIONS MODEL
Our approach integrates agent-based simulation, used to model the inter-host dynamics of patients and
HCWs, with a detailed differential equations model of the intra-host bacterial and antibiotic dynamics.
Each level is discussed in turn below.
3.1 Agent-Based Inter-Host Model
Conceptual Level: The agent-based level of our model facilitates the simulation of interactions among
health-care workers (HCWs) and patients. An agent in the model represents either a single health-care
worker or a single patient. Each agent has a set of characteristics (data), uniquely populated per agent. These
characteristics include blood volume (for computing antibiotic concentrations), a vector characterizing the
current bacteria population in the host (referred to as the bacterial population vector, or BPV, which is
described in more detail in Section 3.2), and antibiotic treatment history, and, for HCWs only, a list of
assigned patients. Each agent also has a set of behaviors (methods) consistent with the actions of the
host being modeled. For example, a HCW has behaviors to model visiting patients on rounds, visiting
patients as a result of patient call, and interacting with other health-care workers. Because the interactions
in our model are driven primarily by the actions of HCWs, a patient currently has behavior only to model
interaction with another patient.
Figure 1 provides a conceptual view of potential agent interactions in our model from a single HCW’s
perspective. Specifically, when a HCW begins a shift, the HCW may spend non-zero time in preparatory
work before moving on to rounds for assigned patients. We presume that an interaction between HCW and
patient is non-preemptive, but at any time between rounds visits, a HCW may interact with another HCW
(e.g., in the hallway) or with another patient as a result of patient call. After one sequence of rounds is
complete, the HCW may spend non-zero time in summary work (e.g., updating charts) before resuming
rounds or ending the shift.
Computational Level: Because the intra-host differential equations model was developed in MATLAB,
we use the object-oriented programming capabilities of MATLAB to implement the agent-based level of
the model. We use an Agent class to model the characteristics and behaviors consistent across all agents,
while Patient and HCW classes extend the Agent class for more specific characteristics and behaviors.
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Figure 1: Activity for one health-care worker in the agent-based model.
We use next-event simulation (Leemis and Park 2006) to drive the time evolution of the model. The
event types currently include the following: (a) HCW visiting patient on rounds; (b) HCW addressing a
patient call; (c) two HCWs interacting; (d) two patients interacting; (e) application of antibiotic to an agent;
(f) end of HCW shift; and (g) discharge of a patient.
As is typical with this type of simulation, the event calendar is kept up-to-date with the time of, and
reference to, the next event in simulated time for each event type. (Note that each Agent object stores the
next event times for each event type for that specific agent, as applicable. The calendar stores only the first
in simulated time for each event type.) The simulation progresses by advancing the simulation clock to the
most imminent event time, handling that particular event, then scheduling new event(s) for the associated
agent, and finally updating the calendar accordingly.
Whenever two agents interact, the agent-based level invokes methods from the differential-equations
level to model the dynamics of bacteria and antibiotics within each of the two agents across time (see
Section 3.2). This corresponds to event types (a)–(d) above. Whenever an agent is to receive antibiotic
treatment, corresponding to event type (e) above, methods from the differential-equations level are again
invoked to model the application and dosage of a specific antibiotic. For event type (f), we presume that
whenever a HCW’s shift ends, a new HCW immediately starts a shift, accepting all the assigned patients
from the exiting HCW. For event type (g), we also presume that patient discharge results in a new patient
assigned immediately in the exiting patient’s stead.
3.2 Differential Equations/Probabilistic Intra-Host Model
An important component of our hospital infection model is to simulate the changes in each agent’s internal
pathogen population over time, as this drives, among other things, the possibilities of bacterial exchange
during agent-interaction events. In light of the goals of this project, it is essential to subdivide an agent’s
bacterial population into different sub-populations, so we organize each agent’s bacteria population into a
bacteria population vector, or BPV, which is stored within the agent object.
To realistically model the transfer of bacteria between agents, it is necessary to distinguish between
different infection states within each agent. We subdivide each agent’s bacterial population into six
infection categories (I-Cats), which reflect six different infection/colonization-states that bear on the spread
of infection, as listed in Table 1. With this structure, the possible bacterial exchanges between the two
types of agents (patient and HCW) are given in Table 2. (Based on an extensive review of the infectious
diseases literature, these possible exchanges are widely accepted. For example, the multiple “yes” entries
in row 4 of Table 2(b) reflect the possibility of a HCW with a skin infection spreading that bacteria to
patients in multiple ways. By contrast, the “no” entries in row 5 of Table 2(b) reflect the unlikelihood of
a HCW with a urinary tract infection spreading that bacteria to patients.) At each agent-interaction event,
random deviates are drawn to determine whether transfer between the allowable I-cat-pairings occur. The
number of bacteria transferred is also determined randomly.
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Table 1: The six “infection categories” (I-Cats), used by the simulation model.
I-Cat Description Examples
1 colonization that can be anticipated and addressed hand or equipment colonization
2 unnoticed colonization — no preemptive action taken nasal carriage of S. aureus
3 present as part of the agent’s regular microflora usual gut bacteria
4 can be self-spread, spread directly agent-to-agent, skin or respiratory infections
or spread via HCW intervention
5 can be self-spread or spread via HCW intervention, urinary tract infections
but not spread directly agent-to-agent
6 can be spread via HCW intervention, bloodstream infections
but not self-spread nor spread directly agent-to-agent
Table 2: Summary of the possible bacterial exchanges between agents. In both tables, each row represents
one of the I-Cats of the donor agent, and each column represents one of the I-Cats of the recipient
agent. Table (a) indicates possible transfers from a patient to a HCW, while table (b) indicates possible
transfers from a HCW to a patient. A “yes” indicates that transfer between those two I-Cats is possible.
Patient-to-patient and HCW-to-HCW transfers are possible, but their tables are not shown here for brevity.
I-Cat=1 I-Cat=2 I-Cat=3 I-Cat=4 I-Cat=5 I-Cat=6
I-Cat=1 yes yes no yes no no
I-Cat=2 yes yes no yes no no
I-Cat=3 yes yes no yes no no
I-Cat=4 yes yes no yes no no
I-Cat=5 yes no no no no no
I-Cat=6 yes no no no no no
(a) Patient-to-HCW Transfer
I-Cat=1 I-Cat=2 I-Cat=3 I-Cat=4 I-Cat=5 I-Cat=6
I-Cat=1 yes yes no yes yes yes
I-Cat=2 yes yes no yes yes yes
I-Cat=3 no no no no no no
I-Cat=4 yes yes no yes yes yes
I-Cat=5 no no no no no no
I-Cat=6 no no no no no no
(b) HCW-to-Patient Transfer
At the start of a simulation run, we select which bacteria species to track, and which antibiotics to
use to treat infections. Each of the agent’s six I-Cats are then subdivided to have one subdivision for each
bacteria species, resulting in the number of subdivisions being equal to 6×(# species). One step further,
each of these 6×(# species) sub-populations are further subdivided according to the possible antibiotic
resistance profiles. To explain what is meant by “resistance profile”, we first note that the resistance-level
of a bacterial strain versus a particular antibiotic can be quantified by the notion of minimum inhibitory
concentration (MIC). The MIC is the minimum concentration of the antibiotic at which the bacteria strain
cannot reproduce. Each chosen (for the simulation) bacteria strain will have one MIC value for each of
Caudill and Lawson
the chosen antibiotics, and we refer to this set of MIC values as that strain’s resistance profile. To make
things precise in our model, at the start of each simulation we choose how many levels of resistance
(which translate into intervals of MIC values) will be included for each antibiotic. This means there are
(# resistance levels)(#antibiotics) different resistance profiles for each bacteria species. This results in
length of BPV = 6× (# species)× (# resistance levels)(#antibiotics) .
An illustration of the structure of the BPV, in the case of two bacteria species, two antibiotics, and two
resistance-levels, is shown in Figure 2.
Figure 2: Structure of an agent’s BPV for the case of two bacterial species, two antibiotics, and two
resistance-levels. The row of boxes along the bottom represents the BPV. For instance, the sixth entry
in the BPV consists of the density of the strain of bacteria #2 in I-Cat #1 that has resistance-level “S”
(“susceptible”) for antibiotic #1 and resistance-level “R” (“resistant”) for antibiotic #2.
Within each agent, we use a combination of differential equations models and probabilistic models (with
parameters specific to that agent) to simulate the key factors that influence the changes, over time, in the
bacteria sub-populations within the agent’s body (i.e., values of the agent’s BPV entries). The differential
equations (DE) system consists of one DE for each BPV entry, and models bacterial reproduction, natural
death, and death due to the presence of antibiotics. We denote the entries in the agent’s BPV as Pi, j,k,
where i indicates the I-Cat, j indicates the bacteria species, and k indicates the resistance profile. (For
example, entry #7 in the BPV in Figure 2 would be P1,2,3.) Then, the DE for each Pi, j,k in the BPV can
be expressed as
dPi, j,k
dt
= (reproduction)− (natural death)− (AB induced death) ,
which, for our model, takes the form
dPi, j,k
dt
= ai, j,kPi, j,k(t)−bi, j,kPi, j,k(t)−di, j,k(t)Pi, j,k(t) , (1)
where ai, j,k and bi, j,k are constants that do not differ between agents, and the function di, j,k(t) has the form
di, j,k(t) =
0 if Cr(t)≤MIC j,r∑#antibioticsr=1 αi, j,k,r(Cr(t)−MIC j,r)βi, j,k,r+γi, j,k,r(Cr(t)−MIC j,r) if Cr(t)> MIC j,r . (2)
In Equation (2), αi, j,k,r, βi, j,k,r, and γi, j,k,r are constants, Cr(t) is the current concentration of antibiotic r,
and MIC j,r is the MIC value of antibiotic r versus bacteria species j.
To accurately reflect the rise and spread of antibiotic-resistant members of an agent’s bacterial population,
our model must also account for the underlying natural selection dynamics within the bacterial sub-
populations. Figure 3 illustrates the process by which improper use of antibiotics (either by using insufficient
dosages or by ending treatment before all bacteria are eliminated) can lead to the rise-to-dominance of
antibiotic-resistant members of those populations. Key to this process is the occasional appearance of
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Figure 3: Process by which antibiotic use can lead to an increase in the proportion of a bacterial population
that are resistant to that antibiotic: (a) With no antibiotic present, susceptible bacteria (light color) dominate.
Random genetic mutations during reproduction yield an occasional antibiotic-resistant mutant (dark color).
(b) With antibiotic present, susceptible bacteria are killed while resistant ones survive. (c) With antibiotic
present, resistant bacteria continue to live and reproduce, while any susceptible bacteria arising from genetic
mutations are killed by the antibiotic, resulting in a purely-resistant population. (d) When antibiotic is
removed, the existing resistant population continues to reproduce, resulting in an occasional susceptible
mutant which can now survive. (e) After one generation, susceptible and resistant bacteria reproduce. (f)
After a short time, resistant bacteria dominate, making the population as a whole more difficult to eradicate
with antibiotics.
resistant individuals in the bacterial population, resulting from random genetic mutations arising during
reproduction of the susceptible bacteria.
Mutation dynamics are less amenable to differential equations modeling, so we utilize a probabilistic
model to allow for the possibility of bacterial genetic mutations (occurring during reproduction) that result
in a change in a bacterium’s resistance-profile. When an agent’s BPV is updated (via the system in
Equation (1)) from the previous event time to the current time, updating is paused at regular time intervals
to allow for some of the newly-created members of the BPV to change from one resistance level to another
via mutation. Specifically, for each nonzero sub-population, we draw a random deviate from a suitable
binomial distribution. These deviates determine, for each entry in the BPV, how many of the newly-created
members of that sub-population will be moved to different resistance-profiles.
4 RESULTS
Before proceeding to our example simulation, we show the results of three proof-of-concept tests using
our implementation. In the first, we test our intra-host differential equation system model (1) by creating
a single agent, with one bacteria species, one antibiotic, and one resistance-level, resulting in a BPV with
six entries, which we set initially to 10, 100, 0, 0, 105, and 0, respectively. The result is a simulation in
which neither bacterial transfer (because there is only one agent) nor mutation (because there is only one
resistance-level) is possible, effectively isolating the DE model as the only active dynamics. The resulting
BPV values over time for the three non-zero I-Cats, in the absence of antibiotic treatment, are illustrated
in Figure 4 (blue dashed curves), and given in CFUs (colony-forming units). We compare these results to
the exact solutions of the DE system in Equation (1), shown by the red solid curves in the same figure. In
each case, point-wise errors are on the order of 10−11, which demonstrates good agreement.
Next, we test the bacterial transfer feature of our implementation by introducing a second agent into
the above setting, so that we have one patient and one HCW. In order to isolate the bacterial transfers, we
set the first entry in the HCW to 104, and the remaining entries in both agents to 0. We turn off the birth
and death dynamics for both agents, so that transfer between agents is the only option for changing these
BPV values. Since the patient’s BPV entries are all zeros, transfer in the first time-step will only occur
from HCW to patient. According to Table 2(b), bacteria in the HCW’s I-Cat = 1 entry can be transferred
to all of the patient’s I-Cats with the exception of I-Cat = 3. If we set the probability for each of these
possible transfers to 1.0 and set the proportion of bacteria transferred to 1%, then we should expect 100
bacteria to be transferred from the HCW’s I-Cat = 1 entry to each of the five possible patient recipient
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Figure 4: Test results for the intra-host DE model, in the absence of antibiotics, for sample agent’s three
non-zero I-Cats. Red curves indicate the exact solutions of the DE system, and blue dashed curves indicate
the numerical solutions provided by our MATLAB implementation.
(a) HCW to Patient (b) Patient to HCW (c) HCW to Patient Example
Figure 5: Possible bacteria transfers (a) from HCW to patient and (b) from patient to HCW. Experimental
results are depicted in (c), where 102 (1%) of the HCW’s original 104 bacteria in the first entry are transferred
to each of five of the patient’s I-Cat categories.
I-Cats. The resulting values generated by our implementation are depicted in Figure 5, and confirm that
this aspect of our implementation is also operating correctly.
In our final test, we investigate the genetic mutation feature by once again considering a single agent,
but with two antibiotics and two resistance-levels. Each of the agent’s I-Cats are now divided into four
entries (because of the four possible resistance profiles, as illustrated in Figure 2), resulting in a BPV with
24 entries. For this test, we initially set P1,1,2 (i.e., the second entry in the BPV) to 105, and the rest to
zero. Mutations within this sub-population will result in bacteria moving from P1,1,2 to the other three
resistance-profiles within I-Cat = 1, as shown in Figure 6. If we set the three related probabilities to the
values indicated in Figure 6, our implementation generates the results shown. The number of mutants from
P1,1,2 into each of the other three sub-populations is consistent with expected values, thereby confirming
that our implementation is handling mutations as intended.
We now demonstrate how our implementation may be used to explore resistance-control measures by
using it to simulate the spread of hospital-acquired pneumonia (HAP) within an intensive care unit. HAP
is the second most common hospital-acquired infection (after urinary tract infections), and a leading cause
of HAI-induced mortality (Torres 2012). HAP is a particular problem within ICUs, where many patients
undergo mechanical ventilation, which provides easy accessibility for pathogens to reach the lungs. The
two most common pathogens implicated in HAP are Staphylococcus aureus and Pseudomonas aeruginosa,
which together account for nearly one-third of cultured cases (Richards et al. 2000). Antibiotic resistant
strains of both of these species (including the well-known methicillin-resistant S. aureus, or MRSA), are
widespread, leading to the need for a large arsenal of antibiotics for treating HAP.
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(a) Mutation dynamics (b) Example mutation
Figure 6: Bacteria mutation within an agent. This figure depicts one I-Cat within the BPV for a single
agent before and after mutation, presuming one bacterium, two antibiotics, and two resistance levels.
Medical researchers have proposed that hospitals screen ICU patients at the first signs of pneumonia,
to identify the specific infecting pathogen (Spellberg et al. 2008). Any resulting positive bacterial cultures
would then be tested for their resistance levels (i.e., MIC values) with respect to the antibiotics most
commonly used to treat them. The intention is to identify infections caused by resistant bacterial strains,
and to avoid attempting to treat them with an ultimately ineffective drug. While this rationale is widely
accepted as sound, in practice many hospitals will culture pneumonia patients only after the first attempt
at antibiotic treatment has proven ineffective, reasoning that the procedure for obtaining sputum samples
from the lung is not only unpleasant for the patient, but also provides an additional opportunity to introduce
pathogenic bacteria into the patient’s lower respiratory system.
Our experiment will focus specifically on HAP caused by infection with S. aureus, and will compare
two treatment strategies which differ only in the use of sputum culturing, as illustrated in Figure 7. In
Treatment 1, patients are cultured only if the initial treatment with imipenem (a broad-spectrum antibiotic
commonly used to treat pneumonia when the specific causative pathogen is not known) is not successful,
resulting in a 24-hour lag time, compared to the immediate culturing of patients undergoing Treatment 2.
Figure 8 shows the results of two simulations. In the first simulation, both patients begin with 105 S.
aureus bacteria, all susceptible to both imipenem and oxacillin, in I-Cat = 4 (the I-Cat that corresponds to
pneumonia). One patient undergoes Treatment 1 while the other patient undergoes Treatment 2. As the
first plot in Figure 8 illustrates, the bacterial load initially decreases identically in both patients (because
both are receiving identical imipenem treatments − 500mg every six hours by IV injection). After 1440
minutes (24 hours), the Treatment 2 patient is changed to oxacillin, which proves to be more effective in
reducing the S. aureus count. Ultimately, both patients are cured, although the Treatment 2 patient recovers
more quickly.
In the second plot in Figure 8, the two patients are again identical, except each now has an infection
with S. aureus that is resistant to imipenem and susceptible to oxacillin. For both patients, the bacterial
load increases over the first 24 hours, at which time the Treatment 2 patient is switched to oxacillin therapy.
At this point, the Treatment 1 patient is cultured, but must wait another 24 hours before lab results indicate
a switch to oxacillin. Consequently, this patient’s bacterial load continues to increase, possibly to lethal
levels, for an additional 24 hours. Even if the higher load is not lethal, Treatment 1 results in a longer
time-to-recovery, which carries a correspondingly higher risk of tissue damage.
5 CONCLUSIONS AND FUTURE WORK
We have presented a new model for simulating the spread of antibiotic-resistant infections in hospital wards.
This model combines an agent-based structure at the patient/HCW interaction level with a combination
differential equations/probabilistic model at the intra-host level. We have demonstrated the ability of
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Figure 7: The two treatment protocols employed in the HAP simulation experiment.
Figure 8: Results of HAP experiment, showing patient bacterial loads in log(CFU) versus time. Patients
with infection susceptible to both imipenem and oxacillin are shown in the left plot, while the right plot
shows those with infections that are resistant to imipenem but susceptible to oxacillin. In both plots, the
patient under Treatment 1 is shown in solid red and the patient under Treatment 2 is shown in dashed blue.
this model to reproduce the basic bacterial and infection dynamics upon which the model is based. We
demonstrated the potential usefulness of this model by investigating two different treatment strategies for
pneumonia caused by S. aureus.
In future work, we will extend this model to incorporate additional factors including:
• Agent self-interaction events: It is often the case that a bacteria species can be harmless in some
agent I-Cats but pathogenic in other I-Cats. It is possible, e.g., through inadequate personal hygiene,
to induce infection in oneself by transferring such bacteria from a “safe” I-Cat to a less-safe one.
We will extend the model to include an event type for agents interacting with themselves, to permit
the transfer of bacteria between I-Cats of a single agent.
• Immune system effects: The immune response to bacterial infection has a great impact on the course
of the infection. In fact, it has been postulated that immunocompromised patients (e.g., the elderly,
and patients in oncology wards or transplant wards) may play an important role in the ability of
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antibiotic-resistant pathogens to survive long-term in hospitals (Moellering and Blumgart 2002).
We will extend our model to include bacteria-immune system interactions (Caudill 2013).
• Indicators of infection severity: Our model currently uses bacteria counts to measure infection
severity. In practice, these numbers are seldom known, and clinicians rely on indirect measures of
infection severity, including body temperature and white blood cell count. We will investigate the
relationship between these quantities and bacterial load to incorporate these indirect signs, thereby
permitting us to more-closely parallel the usual patterns of antibiotic therapy.
• Agent mortality: Currently there is no mechanism whereby an agent can die from infection, regardless
of how large the pathogen load becomes. We will incorporate a mechanism whereby mortality will
become possible for agents with very high bacterial loads in the most sensitive I-Cats.
• Antibiotic toxicity: Any antibiotic, in sufficiently-high concentrations, will be toxic to humans.
We will incorporate the effects of antibiotic toxicity into our model to more accurately reflect the
limitations faced by prescribing medical personnel.
• Complicating physical conditions (e.g., kidney failure): There is a significantly greater risk of toxic
reactions to antibiotics in individuals with certain physical conditions, such as reduced kidney
function. We will extend our model to permit varying degrees of kidney function among the agents
to investigate the effect on the spread of antibiotic resistance.
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